Sickle cell disease (SCD) is marked by chronic hemolysis, systemic endothelial dysfunction, inflammation, and vascular occlusion, leading to severe pain, multi-organ damage, and a median lifespan of 48 years in high-income countries. Young adults with progressive heart, lung, or kidney damage are at heightened risk for premature death.